Only four patients in our cohort had a concomitant treatment with granulocyte colony-stimulating factor (GCSF), and three patients had a history of chronic infection (two with B hepatitis and one with C hepatitis, without circulating virus). Here, CSF3 is linked to hepatitis C virus infection.